The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study

Early Identification of Refractory Epilepsy

Patrick Kwan, Martin J. Brodie · New England Journal of Medicine · 2000 · 5.2K citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

Orrin Devinsky, J. Helen Cross, Linda Laux et al. · New England Journal of Medicine · 2017 · 1.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial

Orrin Devinsky, Eric D. Marsh, Daniel J. Friedman et al. · The Lancet Neurology · 2015 · 895 citations

Medicine, Pharmacology, Pharmacotherapy +13

A National Profile of Childhood Epilepsy and Seizure Disorder

Shirley A. Russ, Kandyce Larson, Neal Halfon · PEDIATRICS · 2012 · 680 citations

Medicine, Child Health, Pediatrics +17

Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients

Jomar M. Cunha, E.A. Carlini, Aparecido E. Pereira et al. · Pharmacology · 2008 · 568 citations

Medicine, Pharmacology, Pharmacotherapy +13